CG Oncology, Inc. Common stock Insider Transactions
CG Oncology, Inc. Common stock Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Song Hong Fang
Director |
Sell | 700,000 @ $28.00 | $19.60 M | 3,003,931 | 12/16/2024 | 12/17/2024 | |
POST LEONARD E
Director |
Sell | 1,000 @ $28.84 | $28,840 | 0 | 12/16/2024 | 12/17/2024 | |
POST LEONARD E
Director |
Sell | 750 @ $34.40 | $25,798 | 250 | 12/06/2024 | 12/06/2024 | |
POST LEONARD E
Director |
Sell | 250 @ $34.98 | $8,744 | 0 | 12/06/2024 | 12/06/2024 | |
Decheng Capital Global Life Sciences Fund IV, L.P.
10 percent owner |
Buy | 400,000 @ $19.00 | $7.60 M | 400,000 | 01/29/2024 | 01/31/2024 |
CG Oncology, Inc. Common stock FAQ's
The list of insiders at CG Oncology, Inc. Common stock includes Decheng Capital Global Life Sciences Fund IV, L.P., POST LEONARD E, Song Hong Fang.
Insiders have sold a total of 702,000 CG Oncology, Inc. Common stock shares in the last 12 months for a total of 19.66 M sold.
The following insiders have sold CG Oncology, Inc. Common stock shares in the last 12 months: POST LEONARD E ($63,382), Song Hong Fang ($19.60 M),
Insiders have purchased a total of 400,000 CG Oncology, Inc. Common stock shares in the last 12 months for a total of 7.60 M.
The following insiders have purchased CG Oncology, Inc. Common stock shares in the last 12 months: Decheng Capital Global Life Sciences Fund IV, L.P. ($7.60 M),